FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to infant cardiology, and can be applied in assessment of chronic cardiac disease (CD) severity for children with innate heard diseases. It involves determination of level indicator for T-terminal predecessor of cerebral natriuretic peptide (NT-pro-BNP) as quantitative criterion. For NT-pro-BNP level value within 15 to 214 pg/ml, 1 functional class of cardiac decompensation is diagnosed (FC 1); for level value within 141 to 898 pg/ml FC 2 is diagnosed, for level value within 962 to 4993 pg/ml FC 3 is diagnosed, for level value within 3626 to 78616 pg/ml FC 4 is diagnosed.
EFFECT: objective and prompt assessment of cardiac decompensation level for the claimed group of patients, enabling timely surgical treatment.
2 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR CRITICAL CONGENITAL HEART DISEASE IN NEWBORNS WITH USING NT-pro-BNP LEVEL | 2013 |
|
RU2538714C1 |
| METHOD OF DIAGNOSING ATRIOVENTRICULAR NODAL ECTOPIC TACHICARDIA IN CHILDREN AFTER SURGICAL TREATMENT OF VALVULAR DEFECTS BY DETECTION OF ATRIOVENTRICULAR DISSOCIATION ON ECG WITH APPLICATION OF MEDICATIONS (ITS VERSIONS) | 2010 |
|
RU2453264C2 |
| METHOD OF EARLY DETECTION OF PERSISTENT PULMONARY HYPERTENSION AND CRITICAL CONGENITAL HEART DEFECTS IN NEONATES | 2016 |
|
RU2648838C1 |
| METHOD OF DISEASE OUTCOME PREDICTION IN ELDERLY AND OLD PATIENTS SUFFERING FROM CARDIAC INSUFFICIENCY | 2007 |
|
RU2353933C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH ACUTE DECOMPENSATION OF ISCHEMIC CHRONIC HEART FAILURE WITH SYSTOLIC DYSFUNCTION OF THE LEFT VENTRICLE OF THE HEART AFTER COMPLETE MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770271C1 |
| DIAGNOSTIC TECHNIQUE FOR FUNCTIONAL CLASS OF CHRONIC CARDIAC FAILURE | 2012 |
|
RU2526800C2 |
| METHOD OF PREDICTING RISK OF DEVELOPING FUNCTIONAL CLASS III CHRONIC HEART FAILURE IN PATIENTS WITH VENTRICULAR TACHYARRHYTHMIAS AND IMPLANTED CARDIOVERTER-DEFIBRILLATOR | 2023 |
|
RU2807272C1 |
| METHOD FOR PREDICTION OF UNFAVOURABLE OUTCOME OF HYPERTROPHIC CARDIOMYOPATHY | 2013 |
|
RU2527768C1 |
| METHOD FOR PREDICTATION OF SUPER RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY FOR PATIENTS WITH CHRONIC HEART FAILURE | 2016 |
|
RU2623487C1 |
| METHOD FOR PREDICTING COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE AFTER CARDIAC SURGERIES WITH ARTIFICIAL CIRCULATION | 2017 |
|
RU2680602C1 |
